Prenatal Exposure Effects Psychophysiology Study
NCT01134770 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-02-04
Summary
The purpose of the study is to understand the biology and behavior of early mother-infant attachment, and to investigate how it may be affected by prenatal substance exposures. The investigators are interested in how drugs such as cocaine, alcohol, marijuana and cigarette smoking affect both mother and baby.
Conditions
- Pregnancy
Sponsors & Collaborators
-
University of North Carolina, Chapel Hill
lead OTHER
Principal Investigators
-
Karen Grewen, PhD · University of North Carolina, Chapel Hill
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers
NCT01569347 ·Status: COMPLETED
-
Brain Imaging: Cocaine Effects & Medication Development - 5
NCT00000270 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Oxytocin on Stress Response in Cocaine-dependent Individuals
NCT01963091 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
NCT00895557 ·Status: WITHDRAWN ·Phase: PHASE2
-
Metabolic Effects of Cocaine
NCT00451230 ·Status: COMPLETED ·Phase: NA
-
Establishing and Eliminating Cue-drug Associations in Human Cocaine Addiction
NCT01978457 ·Status: TERMINATED ·Phase: PHASE1
-
Brain Imaging of Cocaine Craving in Recreational Cocaine Users
NCT01189578 ·Status: COMPLETED
-
D-Cycloserine Facilitation of Cocaine - Cue Extinction
NCT00759473 ·Status: COMPLETED ·Phase: PHASE2
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
Neural Substrates of Emotion: Impact of Cocaine Dependence
NCT02682784 ·Status: COMPLETED ·Phase: PHASE2
-
D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals
NCT00780442 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Cue-reactivity Incubation Study
NCT07091877 ·Status: RECRUITING ·Phase: NA
-
Psilocybin-facilitated Treatment for Cocaine Use
NCT02037126 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Cocaine Addiction Using mGluR5 PET and fMRI
NCT03471182 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence
NCT01984177 ·Status: COMPLETED
-
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
NCT01176591 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders
NCT03953612 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Guanfacine to Reduce Stress-Induced Cocaine/Alcohol Craving and Relapse
NCT00585754 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Assessment of Functional Connectivity in Treatment Engaged Cocaine Users
NCT03554928 ·Status: COMPLETED
-
Examination of Transcranial Focused Ultrasound on Brain Activity in Adults
NCT06477029 ·Status: COMPLETED ·Phase: NA
-
Pharmacologic MRI in Cocaine Addiction
NCT01652378 ·Status: COMPLETED
-
Prepulse Inhibition of Startle in Cocaine Dependence - 7
NCT00015249 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Yohimbine on Cocaine Cue Reactivity
NCT00535002 ·Status: COMPLETED ·Phase: PHASE2
-
Progesterone for the Treatment of Cocaine Dependence - 1
NCT00218257 ·Status: COMPLETED ·Phase: NA